Chronic hyperkalemia in cardiorenal patients: Q&A for the cardio-nephrologists.

Authors

  • Luca Di Lullo UOC Nefrologia e Dialisi, Ospedale L. Parodi – Delfino, Colleferro, Italy
  • Claudio Ronco International Renal Research Institute, Ospedale S. Bortolo, Vicenza, Italy
  • Fulvio Floccari UOC Nefrologia e Dialisi, Ospedale “S. Paolo”, Civitavecchia, Italy
  • Antonio De Pascalis UOC Nefrologia e Dialisi, Ospedale “V. Fazzi”, Lecce, Italy
  • Vincenzo Barbera UOC Nefrologia e Dialisi, Ospedale L. Parodi – Delfino, Colleferro, Italy
  • Rodolfo Rivera Clinica Nefrologica, Ospedale “S.Gerardo”, Monza, Italy
  • Antonio Bellasi UOC Nefrologia e Dialisi, ASST Lariana, Ospedale S. Anna, Como, Italy

DOI:

https://doi.org/10.33393/gcnd.2018.604

Keywords:

Hyperkalemia, Chronic kidney disease, Heart failure, RAASi, Potassium-binder

Abstract

Chronic hyperkalemia is a serious medical condition often present in patients with chronic kidney disease (CKD) and heart failure (HF). It leads to poor outcomes and needs careful management by cardio-nephrologists. CKD, HF, diabetes and use of renin–angiotensin–aldosterone system inhibitors (RAASi) drugs are known to induce hyperkalemia. The current therapeutic options are not optimal as shown by the large number of CKD and HF patients suffering from hyperkalemia. The following review focuses on the main risk factors that lead to the development of hyperkalemia and provides a guide for the correct diagnosis and new approaches to therapy. (Cardionephrology)

Downloads

Download data is not yet available.

Published

2019-01-11

How to Cite

Di Lullo, L., Ronco, C., Floccari, F., De Pascalis, A., Barbera, V., Rivera, R., & Bellasi, A. (2019). Chronic hyperkalemia in cardiorenal patients: Q&A for the cardio-nephrologists. Giornale Di Clinica Nefrologica E Dialisi, 30(3-4), 210–215. https://doi.org/10.33393/gcnd.2018.604

Issue

Section

Cardionephrology

Metrics

Most read articles by the same author(s)

<< < 1 2 3 4 > >>